1611 related articles for article (PubMed ID: 26868212)
21. Using High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients: A Cohort Study.
Walter J; du Fay de Lavallaz J; Koechlin L; Zimmermann T; Boeddinghaus J; Honegger U; Strebel I; Twerenbold R; Amrein M; Nestelberger T; Wussler D; Puelacher C; Badertscher P; Zellweger M; Fahrni G; Jeger R; Kaiser C; Reichlin T; Mueller C
Ann Intern Med; 2020 Feb; 172(3):175-185. PubMed ID: 31905377
[TBL] [Abstract][Full Text] [Related]
22. The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function.
Xu L; Qian W; Li W; Liu J; He H; Li G; Cao Y; Yu Y
Peptides; 2014 Feb; 52():143-8. PubMed ID: 24412773
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
[TBL] [Abstract][Full Text] [Related]
24. 25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study.
Michos ED; Selvin E; Misialek JR; McEvoy JW; Ndumele CE; Folsom AR; Ballantyne CM; Lutsey PL
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821403
[TBL] [Abstract][Full Text] [Related]
25. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
[TBL] [Abstract][Full Text] [Related]
26. Association of GDF-15, hs-cTnT and NT-proBNP with coronary artery disease in patients undergoing elective angiography.
Souaid T; Hijazi Z; Barakett V; Sarkis A; Kadri Z; Batra G; Lindbäck J; Abdelmassih T; Azar RR
Future Cardiol; 2022 Aug; 18(8):635-646. PubMed ID: 35678322
[TBL] [Abstract][Full Text] [Related]
27. Potential predictors for mental stress-induced myocardial ischemia in patients with coronary artery disease.
Liu MY; Yang Y; Zhang LJ; Pu LH; He DF; Liu JY; Hafeez A; Ding YC; Ma H; Geng QS
Chin Med J (Engl); 2019 Jun; 132(12):1390-1399. PubMed ID: 31205095
[TBL] [Abstract][Full Text] [Related]
28. Troponin T and N-terminal pro B-Type natriuretic peptide and presence of coronary artery disease.
Mouridsen MR; Sajadieh A; Carlsen CM; Mattsson N; Heitmann M; Nielsen OW
Scand J Clin Lab Invest; 2015 May; 75(3):204-12. PubMed ID: 25629204
[TBL] [Abstract][Full Text] [Related]
29. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Giannitsis E; Spanuth E; Horsch A; Kleber ME; Koch W; Grammer TB; Koenig W; März W
Clin Chem Lab Med; 2013 Oct; 51(10):2019-28. PubMed ID: 24072576
[TBL] [Abstract][Full Text] [Related]
30. High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study.
Ivandic BT; Spanuth E; Kleber M; Grammer TB; März W
Clin Chem Lab Med; 2011 Jun; 49(6):1053-8. PubMed ID: 21574877
[TBL] [Abstract][Full Text] [Related]
31. Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients.
Leowattana W; Ong-Ajyooth L; Taruangsri P; Pokum S
J Med Assoc Thai; 2003 May; 86 Suppl 1():S52-8. PubMed ID: 12866769
[TBL] [Abstract][Full Text] [Related]
32. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
33. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide.
Jungbauer CG; Riedlinger J; Buchner S; Birner C; Resch M; Lubnow M; Debl K; Buesing M; Huedig H; Riegger G; Luchner A
Clin Chem Lab Med; 2011 Nov; 49(11):1899-906. PubMed ID: 21892905
[TBL] [Abstract][Full Text] [Related]
34. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
[TBL] [Abstract][Full Text] [Related]
35. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
[TBL] [Abstract][Full Text] [Related]
36. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
[TBL] [Abstract][Full Text] [Related]
37. Cardiac troponin T and NT-proBNP for detecting myocardial ischemia in suspected chronic coronary syndrome.
Myhre PL; Røsjø H; Sarvari SI; Ukkonen H; Rademakers F; Engvall JE; Hagve TA; Nagel E; Sicari R; Zamorano JL; Monaghan M; D'hooge J; Edvardsen T; Omland T
Int J Cardiol; 2022 Aug; 361():14-17. PubMed ID: 35577165
[TBL] [Abstract][Full Text] [Related]
38. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
[TBL] [Abstract][Full Text] [Related]
39. N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease.
Scharhag J; Herrmann M; Weissinger M; Herrmann W; Kindermann W
Clin Res Cardiol; 2007 Apr; 96(4):218-26. PubMed ID: 17323015
[TBL] [Abstract][Full Text] [Related]
40. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
Cameron SJ; Sokoll LJ; Laterza OF; Shah S; Green GB
Clin Chim Acta; 2007 Feb; 376(1-2):168-73. PubMed ID: 17011538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
